Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)
Clinical trial NCT00702715 · COMPLETED
Trial details
- NCT number
- NCT00702715
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-24
- Primary completion
- 2010-03-15
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.